NEU 3.16% $13.18 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-112

  1. 2,451 Posts.
    lightbulb Created with Sketch. 477
    They have been known ( bo) to take calculated risks before. With Neu record of high bar results to date, to get in before other phase II results are proven, I too also reckon there will be a tole of the dice soon. Lets see. Pure spec on my part.
    Last edited by Kerebrad: 03/01/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.